QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=2275528ED4C7BB37CFFFFE872EDAA649;jsessionid=F37225ACECE3601B780A105FDEB0925E;jsessionid=C376305D37AF49C0F8B371AC98CCAD0D;jsessionid=E186C5FEEFF98927184583D1AE93A7EB;jsessionid=9333E4644408979335DD5A16C397CA2F (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=2275528ED4C7BB37CFFFFE872EDAA649;jsessionid=F37225ACECE3601B780A105FDEB0925E;jsessionid=C376305D37AF49C0F8B371AC98CCAD0D;jsessionid=E186C5FEEFF98927184583D1AE93A7EB;jsessionid=9333E4644408979335DD5A16C397CA2F